Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:ALGN
NasdaqGS:ALGNMedical Equipment

Why Align Technology (ALGN) Is Up 15.1% After Record 2025 Aligner Volumes And Measured 2026 Outlook

In early February 2026, Align Technology reported fourth-quarter 2025 revenue of US$1,047.56 million and net income of US$135.76 million, capping a full year of just over US$4.03 billion in sales and slightly higher earnings per share than 2024. Alongside these results, Align guided to modest 2026 revenue growth and highlighted record clear aligner volumes, expanding dental service organization partnerships, and continued investment in digital orthodontic technology, including its iTero...
NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

A Look At BioMarin Pharmaceutical (BMRN) Valuation After Recent Share Price Momentum

Setting the scene for BioMarin Pharmaceutical BioMarin Pharmaceutical (BMRN) has been drawing attention after recent share price swings, with a 1 day return of 1.7% and a past 3 months return of 13.0% catching investor eyes. See our latest analysis for BioMarin Pharmaceutical. At a share price of $58.13, BioMarin Pharmaceutical’s recent 90 day share price return of 13.0% contrasts with a 1 year total shareholder return decline of 9.1%. This suggests shorter term momentum alongside weaker...
NasdaqGS:FTNT
NasdaqGS:FTNTSoftware

Fortinet (FTNT) Margin Decline Challenges Bullish Earnings Growth Narratives

Fortinet (FTNT) has wrapped up FY 2025 with fourth quarter revenue of about US$1.9b and basic EPS of US$0.68, alongside net income excluding extra items of US$506m. This gives investors a clear read on its recent trading momentum. The company has seen quarterly revenue move from US$1.66b in Q4 2024 to US$1.91b in Q4 2025, while basic EPS shifted from US$0.69 to US$0.68 over the same period. This sets the scene for a year where margins and profit quality remain in sharp focus. See our full...
TSE:7947
TSE:7947Packaging

Assessing FP Corporation (TSE:7947) Valuation After Strong Nine Month Earnings Update

FP Corporation (TSE:7947) has released earnings for the nine months ended December 31, 2025, giving investors fresh insight into how its packaging business is performing and how profits are tracking this fiscal year. See our latest analysis for FP. The recent earnings update arrives after a period where momentum in FP’s 1 day, 7 day and 90 day share price returns has been positive, even as its 1 year and multi year total shareholder returns remain negative. That mix suggests investors are...
SWX:UBSG
SWX:UBSGCapital Markets

Assessing UBS Group (SWX:UBSG) Valuation After Q4 2025 Results And Credit Suisse Integration Progress

UBS Group (SWX:UBSG) is back in focus after its Q4 2025 report showed net income of US$1.2b and full year profit of US$7.8b, along with progress on the Credit Suisse integration. See our latest analysis for UBS Group. The latest Q4 results, higher proposed dividend and the new share repurchase plan have arrived after a mixed run in the share price, with a 30 day share price return of 9.4% decline but a 90 day share price return of 11.53% and a 1 year total shareholder return of 14.88%,...
NasdaqGS:NEOG
NasdaqGS:NEOGMedical Equipment

Neogen Recall Puts Veterinary Quality Controls And Investor Confidence In Focus

Neogen Corporation initiated a voluntary recall of its HYCOAT Hyaluronate Sodium Sterile Solution used in veterinary settings. The recall was triggered by microbial contamination identified in certain product lots. The affected product is intended for animal use, and the company has reported adverse events in animals linked to the issue. Neogen is working with the U.S. Food and Drug Administration on the recall process. For investors tracking Neogen (NasdaqGS:NEOG), this recall comes at a...
NasdaqGM:UNB
NasdaqGM:UNBBanks

Union Bankshares (UNB) Earnings Growth And 20.6% Margin Challenge Bearish Narratives

Union Bankshares (UNB) closed FY 2025 with fourth quarter total revenue of US$14.1 million and basic EPS of US$0.60, alongside net income of US$2.7 million. On a trailing twelve month basis, revenue was US$53.7 million with EPS of US$2.43 and net income of US$11.1 million. Over the past year, the company has seen revenue move from US$47.2 million to US$53.7 million on a trailing basis, with EPS shifting from US$1.94 to US$2.43. This sets up a story where improving margins and a 20.6% trailing...
NYSE:BILL
NYSE:BILLSoftware

Bill Holdings Q2 Loss Challenges Bullish Narrative On Revenue Growth And Valuation Discount

BILL Holdings (BILL) just posted Q2 2026 results with revenue of US$414.7 million and a basic EPS loss of US$0.03, alongside net income excluding extra items of a US$2.6 million loss. The company has seen quarterly revenue move from US$362.6 million in Q2 2025 to US$414.7 million in Q2 2026, while basic EPS shifted from a profit of US$0.33 to a loss of US$0.03 over the same period. This puts the spotlight firmly on how efficiently that extra revenue is translating into margins. See our full...
NYSE:YETI
NYSE:YETILeisure

Did YETI’s Manufacturing Shift and Product Expansion Just Recast YETI Holdings' (YETI) Investment Narrative?

In early February 2026, YETI Holdings highlighted that its upcoming full-year results will test its brand strength and margin resilience as it shifts manufacturing from China to Vietnam, Thailand, and Mexico while expanding into soft coolers and bags. Recent analysis also applied Peter Lynch’s Growth at a Reasonable Price framework to YETI, underscoring the company’s mix of growth, profitability, and a cautious financial profile as investors reassess its longer-term potential. With these...
TSX:AQN
TSX:AQNIntegrated Utilities

Algonquin’s Shift To Regulated Utility Puts Valuation And Dividend In Focus

Algonquin Power & Utilities has completed the sale of its non regulated renewable energy business, moving toward a pure play regulated utility model. The company plans to use sale proceeds to reduce debt and support a refreshed leadership team's focus on capital execution. Algonquin faces a busy regulatory calendar, with outcomes that may influence its long term outlook and dividend stability. For investors watching TSX:AQN, this shift comes after a period of scrutiny around its balance...
NYSE:CPA
NYSE:CPAAirlines

Assessing Copa Holdings (NYSE:CPA) Valuation After Strong Recent Share Price Momentum

Why Copa Holdings is on investors’ radar Copa Holdings (NYSE:CPA) has drawn fresh attention after recent trading, with the stock closing at US$154.09. That price sits against annual revenue of US$3,533.554m and net income of US$664.795m. See our latest analysis for Copa Holdings. The recent jump to a 1-month share price return of 20.93%, alongside a 1-year total shareholder return of 78.06%, suggests momentum has been building rather than cooling off for Copa Holdings. If this strength in the...
NYSE:MSGE
NYSE:MSGEEntertainment

Did Strong Q2 Results and Infosys Deal Just Shift Madison Square Garden Entertainment's (MSGE) Investment Narrative?

Madison Square Garden Entertainment Corp. recently reported fiscal second-quarter 2026 results, with revenue rising to US$459.94 million and net income to US$92.72 million, alongside higher earnings per share from continuing operations versus a year earlier. Infosys and the MSG Family of Companies also extended their partnership, including renaming the 5,600-seat Theater at Madison Square Garden as the Infosys Theater and expanding technology-driven fan experiences. Next, we’ll assess how...